GDRA Industry Insight
Inside the Connected-Care Boom: 10 Companies Redrawing the Global mHealth Market
Remote patient monitoring, connected devices, and AI-driven care platforms are pulling healthcare out of the clinic and into the home. Here is what ten real companies reveal about where mHealth is heading — and how big the opportunity really is.
USD 120,852.77 Mn
Market value, 2025
USD 801,216.49 Mn
Projected value, 2040
Healthcare is steadily moving beyond hospitals, clinics, and the periodic physician visit. Connected medical devices, remote patient monitoring (RPM) platforms, chronic-care software, wearable biosensors, and AI-supported clinical workflows now let providers keep a continuous, living connection with patients rather than a snapshot taken every few months.
According to Global Data Route Analytics (GDRA), the Global mHealth Market was valued at USD 120,852.77 million in 2025 and is projected to reach USD 801,216.49 million by 2040, expanding at a CAGR of 13.44%. Growing smartphone penetration, connected-device adoption, remote monitoring, and virtual care are the engines behind that climb.
But the number alone hides the more interesting story: the ecosystem is fragmenting into distinct, specialised layers. The ten companies below — each examined directly from its own current public materials — show exactly how varied "mHealth" has become.
1
1bios Turnkey RPM & CCM built for independent practices
1bios targets a specific customer: the independent practice that wants a monitoring program but lacks the staff to run one. Its answer is a fully turnkey model spanning RPM, CCM, PCM, RTM, and APCM — enrollment, monitoring, care delivery, and billing all handled "under one roof" through its proprietary AI platform and a dedicated U.S.-based care team.
The pitch is growth without added headcount or risk: it guarantees enrollment, care delivery, compliance, and billing success, mapping guaranteed care delivery directly to CPT-code revenue. The platform automatically logs time, vitals, care plans, communications, and billable codes, offers audit-ready documentation on demand, works with 20+ device manufacturers, integrates with the EHR, and can be fully white-labeled — all on HIPAA-compliant, enterprise-grade security.
Why it matters
A large slice of the mHealth opportunity is operational, not technical — letting smaller practices run compliant, revenue-generating monitoring programs they could never staff alone.
Source: 1bioshealth.com
2
Carematix AI-driven RPM with zero-friction cellular devices
Carematix runs an AI-driven RPM platform built for chronic-care management and reimbursement. Its stand-out claim is that it is the only RPM company audited by the FDA, pairing FDA-cleared cellular devices with intelligent data analysis so care teams can spot trends and intervene earlier.
The real differentiator is friction removal: devices arrive ready to use out of the box — no apps, no Bluetooth pairing, no home internet required. That single design choice is what makes the model workable for rural and underserved patients. Layered on top are configurable alerts, automated reminders, 24/7 portal access, reporting, EMR integration, and AI tools — with go-live typically inside 7–10 days and no implementation fees.
Why it matters
Simplifying the bridge between home devices, patient-generated data, and provider workflow — rather than relying on standalone apps — is one of mHealth's clearest opportunities.
Source: carematix.com
3
Empo Health Disease-specific monitoring for diabetic foot ulcers
Empo Health is deliberately narrow. Instead of a broad chronic-disease platform, it targets one high-stakes problem: in-home monitoring of diabetic foot complications, which put over 20 million Americans with diabetic neuropathy at risk of ulcers, hospitalisation, and amputation.
The solution pairs the Empo Footprint — an in-home imaging scale — with the Empo Remote Health Link monitoring service. A patient simply steps on it as they would any weight scale; high-resolution foot images and weight data are captured and routed automatically to their care team, backed by nurse-supported monitoring and a practice-facing web app. It's designed to fit existing reimbursement and value-based-care pathways.
On July 30, 2026, Empo announced a peer-reviewed clinical publication, the APMA Seal of Approval, and SOC 2 Type 2 compliance — milestones pointing to real adherence, clinical utility, and data-security maturity.
Why it matters
Deep, disease-specific monitoring can capture information that once depended entirely on a physical exam — proving that focus, not breadth, is sometimes the bigger opportunity.
Source: empohealth.com
4
Vivo Care Service-supported RPM with US nurse-led monitoring
Vivo Care extends chronic-disease management "beyond the exam room" by combining software, connected devices, and US nurse-led clinical support across RPM and Chronic Care Management (CCM) programs. Its framing is pointed: nearly 76% of American adults live with at least one chronic condition, and those illnesses drive over 90% of national healthcare spending.
The platform is built for physician practices, health systems, ACOs, FQHCs, and value-based-care providers, spanning specialties and conditions including hypertension, diabetes, weight management, COPD, and kidney care. Its core promise is turning home-generated vitals into real-time, usable data — with a nurse team acting as an extension of the practice's own staff, backed by SOC 2 and HIPAA-compliant practices.
Why it matters
The rise of service-supported RPM — technology bundled with a clinical team, not sold as software alone — is one of the market's defining shifts.
Source: vivocaresolutions.com
5
DocsInk Unified care-management platform with EHR connectivity
DocsInk pulls the whole digital-care stack into one environment: RPM, CCM, one-tap telehealth, HIPAA-secure messaging, mobile charge capture, and EHR connectivity. It describes itself as a device-agnostic, multi-channel engagement platform used by thousands of healthcare professionals daily, integrating with the nation's leading EHRs — athenahealth, Epic, Allscripts, Cerner, NextGen, and more.
Its CCM tools let providers track patients, aggregate care-management time, log clinical tasks, and monitor progress, while ready-to-use condition-based care plans and SMS campaign templates help manage patients at scale across comorbidities such as diabetes, hypertension, COPD, CHF, and obesity. One-tap telehealth links clinicians and patients over audio/video without app downloads — with the ability to bill instantly.
Why it matters
Organisations increasingly want one integrated digital-care backbone instead of separate systems for telehealth, monitoring, messaging, and chronic care.
Source: docsink.com
6
KangarooHealth All-in-one connected-care platform, 50+ conditions
KangarooHealth positions itself as an all-in-one connected-care platform spanning RPM (Remote Physiological Monitoring), RTM, CCM, PCM, and APCM, plus a GUIDE dementia program. It supports over 50 chronic and high-risk conditions and works with a wide range of compatible connected devices, wrapping data, configurable care pathways, clinical monitoring, billing support, and implementation into a single system.
The platform leans on real-time monitoring and tiered alerts to help teams catch warning signs and prioritise intervention, incorporating symptoms, patient-reported outcomes, and daily vitals alongside phone, SMS, and app-based communication — including multilingual nurse support and high nurse-to-patient ratios. It reports 6 million+ physiological data points, 200,000+ monitoring hours, a 48% reduction in adverse events, and AI-powered analytics to surface what matters clinically.
Why it matters
RPM is evolving from simple device connectivity into multi-condition connected-care platforms that fuse data, clinical services, communication, and workflow.
Source: kangaroohealth.com
7
Optimize Health Medical Technology-enabled aged care & medical-centre support
Optimize Health Medical (OHM) sits apart from the rest of this group. Its current public positioning centres on medical-centre operations and aged-care support in Australia — GP recruitment, nursing support, payroll and bookkeeping, customised business support, and "innovated technology" for medical centres and aging communities, alongside house-call and elderly-care services.
Based on its current website, OHM is best understood as a healthcare-services and technology-enabled care organisation rather than a dedicated RPM technology vendor. Even so, its focus on aged care, home-based services, and technology-supported coordination places it squarely adjacent to a major mHealth frontier.
Why it matters
Using digital systems to coordinate care for aging populations outside the hospital is one of mHealth's largest — and least saturated — adjacent opportunities.
Source: optimizehealthmedical.com.au
8
Ceras Health AI-powered Digital Transitions of Care™ platform
Ceras Health delivers digital connected care through a unified data-and-care platform that fuses real-time monitoring with AI-driven insights. Its offering spans preventative programs, continuous health monitoring, ongoing chronic-condition care, post-discharge care, and wellbeing management — and it reports 35,000 lives touched, 2M+ patient interactions, and around USD 1,475 in annual healthcare-cost reduction per patient.
Its Ceras.AI Digital Transitions of Care™ platform follows a five-step flow — physiological data collection, health-parameter analysis, proactive intervention, healthcare-data exchange, and real-time outcome measurement — powered by predictive analytics and outcome benchmarks.
Why it matters
Collecting data is only step one. The next stage of mHealth is interpreting incoming information, flagging risk, and telling care teams when to act.
Source: cerashealth.com
9
MedTel Healthcare Connected-care ecosystem for emerging health systems
MedTel Healthcare is building a connected-care ecosystem around remote monitoring, connected devices, and virtual-care programs — combining smart devices, an evidence-based platform, clinician supervision, and personalised patient engagement. Its device portfolio includes Bluetooth-enabled glucometers, blood-pressure monitors, weighing scales, fetal-heart monitors, and hemoglobinometers.
Its digital-health programs span diabetes, hypertension, pregnancy, population health, and post-discharge care, operating in both one-to-one (remote monitoring) and one-to-many (population screening) models. With reported reach into government and grassroots programs — including collaborations touching hundreds of thousands of ANMs and millions of patients — MedTel illustrates how connected devices, teleconsultation, and RPM can extend clinical reach into geographically dispersed populations.
Why it matters
In emerging healthcare systems, mHealth's biggest role may be extending clinical reach to the "last mile" — rural clinics, sub-centres, and mobile health units.
Source: medtel.io
10
MediBioSense Medically certified continuous wearable monitoring
MediBioSense focuses on continuous physiological monitoring through medically certified wearables. Its portfolio includes the VitalPatch chest-worn biosensor, the MBS Infinity watch, the MBS LifeStone spot-check device, the HealthStream clinical platform, and ECG monitoring — all feeding into one clinical dashboard.
Rather than four readings a day, its technology streams eight vital signs continuously — heart rate, ECG, respiration, blood oxygen, temperature, blood pressure, posture/activity, and falls — into HealthStream for real-time monitoring, alerts, ECG reporting, and AI-supported insight. Deployed across 60+ countries with 100,000+ VitalPatch deployments and 700,000+ monitoring days, it spans virtual wards, cardiac monitoring, home RPM, research, and defence. One NHS respiratory and frailty virtual ward reported 82% fewer re-admissions over six months.
Why it matters
The move from occasional home readings to continuous physiological streams enables far earlier detection of patient deterioration.
Source: medibiosense.com
What These Companies Reveal About the Future of mHealth
Taken together, these nine companies show that mHealth has grown far beyond "mobile health apps." Several distinct technology layers are maturing at once:
Connected Medical Devices
BP monitors, glucometers, scales, and biosensors are generating clinical data outside facilities. Carematix, MedTel, KangarooHealth, Empo Health, and MediBioSense each attack this differently.
RPM Platforms
The digital bridge between patients, devices, and clinicians. Carematix, Vivo Care, DocsInk, and KangarooHealth fuse monitoring with alerts, communication, and workflow.
Disease-Specific Monitoring
Empo Health's diabetic-foot focus proves that deep, narrow clinical problems can be as valuable as broad general-purpose platforms.
Continuous Monitoring
MediBioSense's wearables show the shift toward always-on physiological data for virtual wards, cardiac care, and home management.
AI & Predictive Insights
Ceras Health, Carematix, KangarooHealth, and MediBioSense use analytics to interpret data, flag trends, and drive proactive intervention.
Care Beyond the Hospital
Across every model, one direction is constant: continuous patient–provider connection replacing episodic clinic visits.
Global mHealth Market Outlook
This expanding ecosystem of platforms, connected devices, monitoring systems, and digital-health services underpins a much larger transformation in care delivery.
GDRA estimates the Global mHealth Market will grow from USD 120,852.77 million (2025) to USD 801,216.49 million (2040), a CAGR of 13.44%.
The GDRA study analyses the market across mHealth applications and software, connected devices, services, wearables, connected home-health devices, monitoring functions, clinical use cases, therapeutic areas, care settings, deployment models, connectivity technologies, and geographies — with opportunity extending well beyond conventional health apps into connected diagnostics, continuous monitoring, disease-management platforms, virtual care, clinical workflow technology, and AI-supported remote healthcare.
Explore the Research
Global mHealth Market Research Report, 2020–2040
Full segmentation, regional breakdowns, and 15-year forecasts from Global Data Route Analytics.
Source: Company websites and independent analysis by Global Data Route Analytics (GDRA). All market data derived exclusively from GDRA's own research. Company details reflect each firm's current public materials at the time of writing.
